ABL Bio Inc (298380) - Total Liabilities

Latest as of December 2025: ₩124.24 Billion KRW ≈ $84.19 Million USD

Based on the latest financial reports, ABL Bio Inc (298380) has total liabilities worth ₩124.24 Billion KRW (≈ $84.19 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of ABL Bio Inc to assess how effectively this company generates cash.

ABL Bio Inc - Total Liabilities Trend (2016–2025)

This chart illustrates how ABL Bio Inc's total liabilities have evolved over time, based on quarterly financial data. Check 298380 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

ABL Bio Inc Competitors by Total Liabilities

The table below lists competitors of ABL Bio Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Enstar Group Limited NASDAQ:ESGR	USA	$14.13 Billion
ExlService Holdings Inc NASDAQ:EXLS	USA	$781.24 Million
Jiangsu Boqian New Materials Stock Co Ltd SHG:605376	China	CN¥333.09 Million
Subsea 7 S.A F:SOCA	Germany	€4.03 Billion
Compagnie Generale des Etablissements Michelin SCA LSE:0OFM	UK	€18.39 Billion
TDG Holding Co Ltd SHG:600330	China	CN¥3.54 Billion
Petronas Dagangan Bhd KLSE:5681	Malaysia	RM4.84 Billion
ASM Pacific Technology Limited F:AY7A	Germany	€8.98 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down ABL Bio Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ABL Bio Inc stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.43	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.80	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.44	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how ABL Bio Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for ABL Bio Inc (2016–2025)

The table below shows the annual total liabilities of ABL Bio Inc from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩124.24 Billion ≈ $84.19 Million	+92.03%
2024-12-31	₩64.70 Billion ≈ $43.84 Million	-24.83%
2023-12-31	₩86.07 Billion ≈ $58.33 Million	-25.59%
2022-12-31	₩115.67 Billion ≈ $78.39 Million	+1117.57%
2021-12-31	₩9.50 Billion ≈ $6.44 Million	+2.93%
2020-12-31	₩9.23 Billion ≈ $6.25 Million	-15.28%
2019-12-31	₩10.89 Billion ≈ $7.38 Million	-8.50%
2018-12-31	₩11.91 Billion ≈ $8.07 Million	-88.80%
2017-12-31	₩106.32 Billion ≈ $72.05 Million	+441.66%
2016-12-31	₩19.63 Billion ≈ $13.30 Million	--

About ABL Bio Inc

KQ:298380 Korea Biotechnology

Market Cap

$5.04 Billion

₩7.43 Trillion KRW

Market Cap Rank

#3574 Global

#93 in Korea

Share Price

₩134800.00

Change (1 day)

-5.07%

52-Week Range

₩59700.00 - ₩245500.00

All Time High

₩245500.00